Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial

J Am Coll Cardiol. 2013 Sep 24;62(13):1214-5. doi: 10.1016/j.jacc.2013.06.014. Epub 2013 Jul 10.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / administration & dosage*
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Infusions, Intravenous
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / surgery
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab